Your browser doesn't support javascript.
loading
PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer.
Scerri, Jeanesse; Scerri, Christian; Schäfer-Ruoff, Felix; Fink, Simon; Templin, Markus; Grech, Godfrey.
Afiliação
  • Scerri J; Department of Physiology & Biochemistry, University of Malta, Msida, Malta.
  • Scerri C; Department of Physiology & Biochemistry, University of Malta, Msida, Malta.
  • Schäfer-Ruoff F; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany.
  • Fink S; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany.
  • Templin M; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany.
  • Grech G; Department of Pathology, University of Malta, Msida, Malta.
Front Endocrinol (Lausanne) ; 13: 1010092, 2022.
Article em En | MEDLINE | ID: mdl-36329884
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Malta
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Malta